ราคาของ Intercept Pharmaceuticals, Inc. (ICPT) คืออะไร

ราคาของ Intercept Pharmaceuticals, Inc. (ICPT) คือ $19.00

หมวกตลาดของ Intercept Pharmaceuticals, Inc. คืออะไร (ICPT)

ฝาครอบตลาดของ Intercept Pharmaceuticals, Inc. (ICPT) คือ $629.64M

ประวัติราคาของ Intercept Pharmaceuticals, Inc. (ICPT)

Intercept Pharmaceuticals, Inc. is a biopharmaceutical firm specializing in the advancement and market launch of therapies designed to treat progressive, non-viral liver conditions. Its operational reach spans the United States, Europe, and Canada. The company currently markets Ocaliva, a medication functioning as a farnesoid X receptor (FXR) agonist. This drug is approved for the treatment of primary biliary cholangitis (PBC) in adults, specifically when administered alongside ursodeoxycholic acid. Beyond its existing approved indications, Intercept is actively investigating Ocaliva's potential for additional uses, notably including nonalcoholic steatohepatitis (NASH). Concurrently, it is progressing other drug candidates through various clinical and preclinical stages of development. In a collaborative effort, the company holds a licensing agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. Intercept distributes its products through a dual approach, utilizing both its proprietary commercial organization and a network of external third-party distributors. The company was founded in 2002 and is headquartered in New York, New York.

ปี	ประสิทธิภาพ
2023	39.35%
2022	-16.08%
2021	-46.76%
2020	-74.21%
2019	16.21%
2018	65.23%
2017	-41.82%
2016	-32.31%
2015	8.19%
2014	138.13%
2013	92.89%
2012	0.00%

ปี

ประสิทธิภาพ

2023

39.35%

2022

-16.08%

2021

-46.76%

2020

-74.21%

2019

16.21%

2018

65.23%

2017

-41.82%

2016

-32.31%

2015

8.19%

2014

138.13%

2013

92.89%

2012

0.00%

บริษัท	ราคาหุ้น	การเปลี่ยนแปลง 1ปี%	ประเทศ
Vertex Pharmaceuticals Incorporated VRTX.US	$542.09	38.63%	US
Argenx SE ARGX.US	$1.03K	44.13%	NL
CSL Limited CSL.AX	$121.36	-12.82%	AU
Moderna, Inc. MRNA.US	$138.18	473.58%	US
Lonza Group AG LONN.SW	$759.27	7.20%	CH

บริษัท

ราคาหุ้น

การเปลี่ยนแปลง 1ปี%

ประเทศ